In the News

In the Newp14
September 11, 2013: KAHR Medical raises $2.35M from Thomas Elderad, Sanofi and Hadasit Bio

June 25, 2012: KAHR Medical raises $2.6M from Thomas Elderad, Sanofi and Hadasit Bio

December 15, 2011: KAHR Medical Raises 2.5M NIS from the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel

September 12, 2011: KAHR's Scientific Advisory Board met in Palo-Alto, California

Spetember 11, 2011: KAHR presented pre-clinical data on KAHR-101 treatment of renal cancer at the Annual Meeting of the German Society of Nephrology in Berlin, Germany

May 24, 2011: KAHR Medical invited to present at the annual BioMed conference in Tel-Aviv

May 23, 2011: KAHR Medical selected as one of Israel's most promising biotechnology companies by the "Calcalist" business magazine (Download article PDF)

April 14, 2011: KAHR Medical raises 5 million dollars ($3 million in cash) from Sanofi-Aventis and Hadasit Bio Holdings

June 14, 2010: KAHR Medical invited to present at the annual BioMed conference in Tel-Aviv

June 13, 2010: KAHR Medical was selected as one of Israel's most promising biotechnology companies by the 'TheMarker' business magazine

January 8, 2010: KAHR Medical's Scientific Advisory Board met in Palo Alto (CA, USA) to discuss the pre-clinical results for the lead product KAHR-101 and its future clinical development

January 2010: KAHR Medical was invited to present at two major scientific meetings in Europe and the United States: The Ninth Annual PepTalk Conferences (San Diego, January 14, 2010) and The Ninth International Conference on New Trends in Immunosuppression (Geneva, February 2010)

December 24, 2009: KAHR Medical raises 1.5 million NIS from Hadasit Bio-Holdings.

May 4, 2009: Globes, Israel's premier business newspaper, presents a video web report on KAHR Medical. (View the report's Hebrew version on the Globes website, or the English version on Utube or from this site

February 19,2009: KAHR's Third-Generation Biologics Attract Financing (BioWorld Today, By Trista Morrison). (Download Article PDF,  Download the BioWorld issue)

January 28, 2009: KAHR Medical Raises $500K from Hadasit Bio-Holdings and the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel

October 17, 2008: KAHR Medical's Scientific Advisory Board met in New-York (USA) to discuss future clinical development for pipeline products